白内障手术后眼内炎的抗生素预防：2021 年 ASCRS 会员调查结果。
Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey.
机构信息
From the University of California, San Francisco, San Francisco, California (Chang); and the Case Western Reserve University, Cleveland, Ohio (Rhee).
出版信息
J Cataract Refract Surg. 2022 Jan 1;48(1):3-7. doi: 10.1097/j.jcrs.0000000000000757.
In an online survey of >1200 global cataract surgeons, 66% were using intracameral (IC) antibiotic prophylaxis. This compared with 50% and 30% in the 2014 and 2007 surveys, respectively. Irrigation bottle infusion and intravitreal injection was each used by only 5% of respondents. For IC antibiotics, vancomycin was used by 6% in the United States (52% in 2014), compared with 83% for moxifloxacin (31% in 2014). Equal numbers used compounded moxifloxacin or the Vigamox bottle as the source. There was a decrease in respondents using preoperative (73% from 85%) and postoperative (86% from 97%) topical antibiotic prophylaxis; the latter was not used by 24% of surgeons injecting IC antibiotics. Reasons cited by those not using IC antibiotics include mixing/compounding risk (66%) and being unconvinced of the need (48%). However, 80% believe having a commercially approved IC antibiotic is important; if reasonably priced, this would increase adoption of IC prophylaxis to 93%.
在一项针对超过 1200 名全球白内障外科医生的在线调查中，66%的人使用了眼内（IC）抗生素预防。这一比例与 2014 年和 2007 年的调查相比，分别增长了 50%和 30%。冲洗瓶输注和玻璃体内注射分别仅被 5%的受访者使用。对于 IC 抗生素，美国有 6%的人使用万古霉素（2014 年为 52%），而莫西沙星的使用率为 83%（2014 年为 31%）。同样数量的受访者使用复合莫西沙星或 Vigamox 瓶作为抗生素的来源。使用术前（从 85%降至 73%）和术后（从 97%降至 86%）局部抗生素预防的受访者数量有所减少；24%注射 IC 抗生素的外科医生不再使用后者。那些不使用 IC 抗生素的人列举的原因包括混合/配制风险（66%）和对使用 IC 抗生素的必要性缺乏信心（48%）。然而，80%的人认为拥有一种获得商业批准的 IC 抗生素很重要；如果价格合理，这将使 IC 预防的使用率增加到 93%。
Zotero 插件